Screamin Menthol Toast

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the relief of specific pain or injury. It is particularly recommended for individuals suffering from arthritis. For optimal results, patients should apply the drug three times daily for a duration of two weeks, after which it may be used as needed.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied directly to the region of specific pain or injury. It is essential to ensure that the affected area is clean and dry prior to application. The frequency and amount of application may vary based on the severity of the condition and the healthcare provider's recommendations. Care should be taken to avoid contact with eyes and mucous membranes.

Contraindications

Use of this product is contraindicated immediately before or after bathing or using a hot tub, as well as in conjunction with heating pads or under wrappings or bandages where perspiration is likely to occur.

Additionally, contact with eyes, mucous membranes, open wounds, cuts, abrasions, and areas where skin touches skin should be avoided. Increased perspiration may heighten the sensation of heat, and in case of eye irritation, rinse with cold water.

Warnings and Precautions

External use of this product is strictly advised. It is imperative to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Users should refrain from applying the product immediately before or after bathing or using a hot tub. Additionally, it should not be used in conjunction with heating pads or under wrappings or bandages where perspiration is likely to occur, as this may exacerbate the effects of the product.

Should excessive irritation arise, or if the condition worsens, it is essential to discontinue use and consult a healthcare professional. If symptoms persist for more than 7 days or if they resolve and then recur within a few days, medical advice should be sought.

While using this product, it is crucial to avoid contact with the eyes, mucous membranes, open wounds, cuts, and abrasions, as well as areas where skin may come into contact with skin. Users should be aware that perspiration may heighten the sensation of heat. In case of eye irritation, it is recommended to rinse the eyes with cold water immediately.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of excessive irritation, it is advised to discontinue use and consult a healthcare professional. Additionally, if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients should seek medical advice. These precautions are important to ensure the safety and well-being of individuals using the product.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Screamin Menthol Toast (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under the age of 12 should be evaluated by a physician prior to use. It is essential to ensure appropriate assessment and guidance regarding the safety and efficacy of the treatment in this age group.

Geriatric Use

There is no specific information regarding the use of SCREAMIN MENTHOL TOAST - menthol cream in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The product has not been evaluated for safety during pregnancy. There are no specific contraindications mentioned regarding its use in pregnant patients. Additionally, the prescribing information does not provide any specific safety concerns or risks to the fetus associated with the use of this product during pregnancy. No dosage modifications for pregnant individuals are indicated, and the insert does not specify any special precautions for use during this period. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include airway management, monitoring of vital signs, and intravenous fluid administration as necessary. The use of specific antidotes or treatments should be guided by the clinical scenario and the substances involved.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for further guidance on the management of overdose cases. Documentation of the incident and any interventions performed is crucial for ongoing patient care and for reporting purposes.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product immediately before or after bathing or using a hot tub. Additionally, they should avoid using it in conjunction with a heating pad or under any wrapping or bandage where perspiration is likely to occur.

Healthcare providers should counsel patients to stop using the product and consult a doctor if they experience excessive irritation, if their condition worsens, or if symptoms persist for more than 7 days. Patients should also be advised to seek medical advice if symptoms clear up and then recur within a few days.

It is important to instruct patients to avoid contact with eyes, mucous membranes, open wounds, cuts, and abrasions while using the product. They should be made aware that perspiration may increase the sensation of heat. In the event of eye irritation, patients should rinse their eyes with cold water immediately.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are necessary beyond standard storage practices.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Screamin Menthol Toast, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)